VJHemOnc is committed to improving our service to you

COMy Virtual 2020 | Transplant for all eligible MM patients?

VJHemOnc is committed to improving our service to you

Arnon Nagler

Arnon Nagler, MD, Chaim Sheba Medical Center, Tel-Aviv, Israel, discusses the importance of transplant for eligible multiple myeloma (MM) patients, induction regimens and obtaining measurable residual disease (MRD) negativity. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter